Furthermore, loss of syndecan 1 expression in the majority of epithelial tumors like cervical, lung, head and neck, squamous cell, and esophageal cancers is associated with tumor development and reduced patient survival [129]. This evidence concerns the gene SDC1 and neoplasm.